{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T17:02:35Z","timestamp":1776186155613,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Austrian Social Insurance for Occupational Risk"},{"name":"Social Health Insurance Vienna"}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bone.2017.12.002","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T01:05:37Z","timestamp":1512522337000},"page":"154-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Novel familial mutation of LRP5 causing high bone mass: Genetic analysis, clinical presentation, and characterization of bone matrix mineralization"],"prefix":"10.1016","volume":"107","author":[{"given":"K.M.","family":"Roetzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Uyanik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Brehm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Zwerina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Zandieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Czech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Roschger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9923-4920","authenticated-orcid":false,"given":"B.M.","family":"Misof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Klaushofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2017.12.002_bb0005","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1210\/en.2006-1352","article-title":"The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes","volume":"148","author":"Balemans","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2017.12.002_bb0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bone.2017.03.044","article-title":"LRP5: from bedside to bench to bone","volume":"102","author":"Williams","year":"2017","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2017.12.002_bb0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","article-title":"LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development","volume":"107","author":"Gong","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bone.2017.12.002_bb0020","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ejhg.2011.42","article-title":"Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG)","volume":"19","author":"Laine","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bone.2017.12.002_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/338450","article-title":"A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait","volume":"70","author":"Little","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bone.2017.12.002_bb0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.3074","article-title":"WNT signaling in bone homeostasis and disease: from human mutations to treatments","volume":"19","author":"Baron","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2017.12.002_bb0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00223-008-9130-9","article-title":"The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations","volume":"82","author":"Balemans","year":"2008","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2017.12.002_bb0040","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nm.2388","article-title":"Lrp5 functions in bone to regulate bone mass","volume":"17","author":"Cui","year":"2011","journal-title":"Nat. Med."},{"issue":"135","key":"10.1016\/j.bone.2017.12.002_bb0045","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cell.2008.09.059","article-title":"Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum","volume":"28","author":"Yadav","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bone.2017.12.002_bb0050","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S8756-3282(02)00973-0","article-title":"Constant mineralization density distribution in cancellous human bone","volume":"32","author":"Roschger","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.12.002_bb0055","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bone.2007.10.021","article-title":"Bone mineralization density distribution in health and disease","volume":"42","author":"Roschger","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.12.002_bb0060","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.bone.2009.02.021","article-title":"Normative data on mineralization density distribution in iliac bone biopsies of children, adolescents and young adults","volume":"44","author":"Fratzl-Zelman","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.12.002_bb0065","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1086\/368277","article-title":"Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density","volume":"72","author":"Van Wesenbeeck","year":"2003","journal-title":"Am. J. Hum. Genet."},{"issue":"169","key":"10.1016\/j.bone.2017.12.002_bb0070","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1530\/EJE-13-0136","article-title":"Autosomal dominant osteopetrosis revisited: lessons from recent studies","volume":"13","author":"Bollerslev","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bone.2017.12.002_bb0075","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1210\/jc.2013-3958","article-title":"Elevated circulating Sclerostin concentrations in individuals with high bone mass, with and without LRP5 mutations","volume":"99","author":"Gregson","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2017.12.002_bb0080","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/jbmr.2706","article-title":"Mutations in known monogenic high bone mass loci only explain a small proportion of high bone mass cases","volume":"31","author":"Gregson","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.12.002_bb0085","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/jbmr.376","article-title":"Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5","volume":"26","author":"Frost","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.12.002_bb0090","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jbmr.44","article-title":"Patients with high-bone-mass phenotype owing to Lrp5-T253I mutation have low plasma levels of serotonin","volume":"25","author":"Frost","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.12.002_bb0095","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jbmr.2086","article-title":"Measurement of plasma, serum, and platelet serotonin in individuals with high bone mass and mutations in LRP5","volume":"29","author":"Lee","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"12","key":"10.1016\/j.bone.2017.12.002_bb0100","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ejmg.2017.09.001","article-title":"High bone mass due to novel LRP5 and AMER1 mutations","volume":"60","author":"Costantini","year":"2017","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.bone.2017.12.002_bb0105","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.bone.2011.07.034","article-title":"High-bone-mass-producing mutations in the Wnt signaling pathway result in distinct skeletal phenotypes","volume":"49","author":"Niziolek","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.12.002_bb0110","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1288\/00005537-199305000-00002","article-title":"Facial nerve dysfunction in osteopetrosis","volume":"103","author":"Benecke","year":"1993","journal-title":"Laryngoscope"},{"issue":"20","key":"10.1016\/j.bone.2017.12.002_bb0115","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa013444","article-title":"High bone density due to a mutation in LDL-receptor-related protein 5","volume":"346","author":"Boyden","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.bone.2017.12.002_bb0120","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s00198-014-2767-5","article-title":"Serum levels of sclerostin, Dickkopf-1, and secreted frizzled-related protein-4 are not changed in individuals with high bone mass causing mutations in LRP5","volume":"25","author":"Simpson","year":"2014","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.12.002_bb0125","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.bbamcr.2015.11.037","article-title":"Normal hematopoiesis and lack of \u03b2-catenin activation in osteoblasts of patients and mice harboring Lrp5 gain-of-function mutations","volume":"1863","author":"Gal\u00e1n-D\u00edez","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bone.2017.12.002_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/8756-3282(89)90142-7","article-title":"Structural and histomorphometric studies of iliac crest trabecular and cortical bone in autosomal dominant osteopetrosis: a study of two radiological types","volume":"10","author":"Bollerslev","year":"1989","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.12.002_bb0135","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1359\/jbmr.2003.18.6.960","article-title":"High bone mass in mice expressing a mutant LRP5 gene","volume":"18","author":"Babij","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.12.002_bb0140","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bone.2011.03.683","article-title":"Analysis of multiple bone responses to graded strains above functional levels, and to disuse, in mice in vivo show that the human Lrp5 G171V High Bone Mass mutation increases the osteogenic response to loading but that lack of Lrp5 activity reduces it","volume":"49","author":"Saxon","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.12.002_bb0145","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bone.2012.05.023","article-title":"Mechanotransduction in bone tissue: the A214V and G171V mutations in Lrp5 enhance load-induced osteogenesis in a surface-selective manner","volume":"51","author":"Niziolek","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.12.002_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140775","article-title":"Missense mutations in LRP5 associated with high bone mass protect the mouse skeleton from disuse- and ovariectomy-induced osteopenia","volume":"10","author":"Niziolek","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2017.12.002_bb0155","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bone.2004.02.018","article-title":"Bone biomechanical properties in LRP5 mutant mice","volume":"35","author":"Akhter","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.12.002_bb0160","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00774-010-0194-z","article-title":"Intrinsic material properties of cortical bone","volume":"29","author":"Lopez Franco","year":"2011","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2017.12.002_bb0165","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00223-016-0154-2","article-title":"Mice have altered bone matrix composition and improved material toughness","volume":"99","author":"Ross","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2017.12.002_bb0170","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/jbmr.2259","article-title":"Sclerostin deficiency is linked to altered bone composition","volume":"29","author":"Hassler","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.12.002_bb0175","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/154405910708600413","article-title":"Cortical vascular canals in human mandible and other bones","volume":"86","author":"Kingsmill","year":"2007","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bone.2017.12.002_bb0180","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217304428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217304428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T06:12:29Z","timestamp":1539151949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328217304428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":36,"alternative-id":["S8756328217304428"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.12.002","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel familial mutation of LRP5 causing high bone mass: Genetic analysis, clinical presentation, and characterization of bone matrix mineralization","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}